Total Net Assets: Windtree Therapeutics, Inc. (WINT)

Windtree Therapeutics (WINT) is a biotech developer creating tools for the emergency stabilization of patients with severe cardiac pathology. This price chart reflects the market valuation of the asset, which currently stands at 0.01. Quotes depend on a narrow portfolio of drugs in the testing phase and frequent secondary offerings. Meanwhile, strong scientific management ensures trial transparency despite high operating expenses.

Windtree Therapeutics (WINT) focuses on developing critical cardiology drugs to stabilize patients with acute heart failure. The current level of book capitalization digitizes this process by recording the net asset value minus liabilities, allowing investors to distinguish the innovator's fundamental stability from short-term market fluctuations through an analysis of equity dynamics.